Last reviewed · How we verify
NCT07297056
Mindfulness Psychoeducation for Bipolar Disorder
NA trial testing Mindfulness-Based Psychoeducation Program in Bipolar Disorder (BD) in 40 participants. Completed in 4 May 2025.
2 May 2025
Quick facts
| Lead sponsor | Ömer USLU |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 3 March 2025 |
| Primary completion | 2 May 2025 |
| Estimated completion | 4 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Mindfulness-Based Psychoeducation Program
- routine care
Conditions studied
- Bipolar Disorder (BD) — all drugs for Bipolar Disorder (BD) →
- Mindfulness-Based Stress Reduction — all drugs for Mindfulness-Based Stress Reduction →
- Mindfulness Meditation — all drugs for Mindfulness Meditation →
Sponsor
Ömer USLU
Who can join
Adults 18 to 65, any sex, with Bipolar Disorder (BD) or Mindfulness-Based Stress Reduction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled experimental study investigates the effectiveness of a mindfulness-based psychoeducation program on mindfulness, self-compassion, and forgiveness among individuals diagnosed with bipolar disorder. Bipolar disorder is a chronic psychiatric condition characterized by fluctuations in mood, energy, and functional capacity, often accompanied by emotional dysregulation, impaired insight, and challenges in interpersonal relationships. Psychosocial interventions that cultivate emotional awareness and adaptive coping may support recovery and enhance long-term functioning. In this study, 40 clinically stable patients with bipolar disorder were randomly assigned to either an experimental group (n=20) or a control group (n=20). The experimental group received a structured mindfulness-based psychoeducation program, while the control group received no additional intervention beyond usual care. Participants completed pre- and post-intervention assessments using a personal information form, the Mindfulness Scale, the Self-Compassion Scale-Short Form, and the Heartland Forgiveness Scale. Findings demonstrated that individuals who participated in the mindfulness-based psychoeducation program showed significantly greater improvements in mindfulness, self-compassion, and forgiveness compared with the control group. These results suggest that integrating mindfulness-based psychoeducation into routine care may promote emotional resilience, enhance illness insight, support symptom management, and strengthen interpersonal functioning in individuals with bipolar disorder.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07297056
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness-Based Psychoeducation Program
Trials testing the same drug.
- NCT07497802 — Mindfulness-Based Psychoeducation for Women With Gynecological Cancer · NA · not yet recruiting
- NCT07310615 — Mindfulness Psychoeducation for Schizophrenia · NA · completed
- NCT07483918 — Mindfulness-Based Psychoeducation With Substance Use and Anxiety Disorders · completed
Other recruiting trials for Bipolar Disorder (BD)
Currently open trials in the same condition.
- NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
- NCT07589647 — Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic D · NA · recruiting
- NCT07306039 — Feasibility of eLi12 · NA · active not recruiting
- NCT07404085 — Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations · NA · recruiting
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
Other Ömer USLU trials
Trials by the same sponsor.
- NCT07305571 — The Effect of Psychodrama-Based Group Work · NA · completed
- NCT07310615 — Mindfulness Psychoeducation for Schizophrenia · NA · completed
- NCT07365943 — The Effect of Forgiveness-based Motivational Interviewing · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07297056 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ömer USLU
- Last refreshed: 31 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07297056.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing